Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
1551
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.72M | ﹤0.01% |
1,121,380
-117,600
| -9% | -$490K |
|
|
BPFH
1552
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $5.71M | ﹤0.01% |
829,472
-56,828
| -6% | -$398K |
|
1553
Primis Financial Corp
FRST
$413M
| $5.71M | ﹤0.01% |
588,813
-41,700
| -7% | -$401K |
|
1554
John Wiley & Sons Class A
WLY
$2.61B
| $5.71M | ﹤0.01% |
+146,300
| New | +$5.59M |
|
1555
James Hardie Industries
JHX
$18B
| $5.71M | ﹤0.01% |
296,527
-103,400
| -26% | -$1.59M |
|
1556
Gartner
IT
$11.4B
| $5.69M | ﹤0.01% |
46,909
+41,265
| +731% | +$4.77M |
|
1557
Radian Group
RDN
$4.98B
| $5.66M | ﹤0.01% |
364,700
+310,000
| +567% | +$4.59M |
|
1558
Safe Bulkers
SB
$789M
| $5.66M | ﹤0.01% |
4,636,186
+32,200
| +0.7% | +$35.3K |
|
|
JHG
1559
DELISTED
Janus Henderson
JHG
| $5.65M | ﹤0.01% |
266,857
+247,057
| +1,248% | +$4.76M |
|
|
INFN
1560
DELISTED
Infinera Corporation Common Stock
INFN
| $5.65M | ﹤0.01% |
954,300
+657,500
| +222% | +$3.6M |
|
1561
Daktronics
DAKT
$986M
| $5.65M | ﹤0.01% |
1,298,300
+45,400
| +4% | +$201K |
|
|
RVI
1562
DELISTED
Retail Value Inc. Common Shares
RVI
| $5.65M | ﹤0.01% |
4,976,972
-755,397
| -13% | -$855K |
|
1563
Otis Worldwide
OTIS
$27.6B
| $5.65M | ﹤0.01% |
+99,300
| New | +$5.14M |
|
1564
VanEck Junior Gold Miners ETF
GDXJ
$8.49B
| $5.64M | ﹤0.01% |
113,800
-21,100
| -16% | -$893K |
|
1565
Valero Energy
VLO
$98.4B
| $5.63M | ﹤0.01% |
95,688
+76,600
| +401% | +$4.58M |
|
1566
ANI Pharmaceuticals
ANIP
$1.76B
| $5.61M | ﹤0.01% |
173,400
-88,900
| -34% | -$3.19M |
|
1567
Victory Capital Holdings
VCTR
$7.27B
| $5.57M | ﹤0.01% |
324,114
+9,638
| +3% | +$151K |
|
|
CALA
1568
DELISTED
Calithera Biosciences, Inc
CALA
| $5.57M | ﹤0.01% |
52,756
-2,748
| -5% | -$326K |
|
1569
First Community Bankshares
FCBC
$936M
| $5.57M | ﹤0.01% |
248,100
-6,700
| -3% | -$145K |
|
|
ICAD
1570
DELISTED
iCAD Inc
ICAD
| $5.57M | ﹤0.01% |
557,370
-102,200
| -15% | -$1.1M |
|
1571
Provident Financial
PROV
$113M
| $5.56M | ﹤0.01% |
414,847
-13,800
| -3% | -$180K |
|
1572
Rogers Corp
ROG
$2.55B
| $5.56M | ﹤0.01% |
44,600
+27,325
| +158% | +$2.92M |
|
|
KE
1573
Kimball Electronics
KE
$622M
| $5.55M | ﹤0.01% |
410,275
-20,300
| -5% | -$261K |
|
1574
1-800-Flowers.com
FLWS
$262M
| $5.54M | ﹤0.01% |
276,532
+252,692
| +1,060% | +$4.98M |
|
1575
First Northwest Bancorp
FNWB
$109M
| $5.54M | ﹤0.01% |
445,705
-15,200
| -3% | -$179K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.